Merck draws attention as healthcare strength, pharma activity, and defensive market rotation place large drugmakers back in ...

Merck remains in focus after important pipeline developments, new product approvals, and clinical progress strengthen ...

NEW YORK, Dec 11 (Reuters) - Merck & Co said on Tuesday it plans to begin late-stage trials next year on a drug to raise "good" HDL cholesterol that has not been dogged by the problems that sank a ...

Merck on Tuesday said it will slash $3 billion in costs by the end of 2027 to be fully reinvested to support new product launches and its drug pipeline. The multiyear effort comes as Merck prepares to ...

Over the past twelve months, the stock of New Jersey-headquartered Pharma giant Merck & Co., Inc. (MRK) has quietly increased by a sector-leading 55%. However, on a three-year basis, its stock is up ...

46th Annual Healthcare Conference. We are absolutely delighted to have Merck senior leadership here with us today. Representing the company, Caroline Litchfield, who is Executive Vice President and ...

Sum of quarterly amounts may not equal year-to-date amounts due to rounding. (1) Only select products are shown. (2) Alliance Revenue represents Merck’s share of profits, which are product sales net ...